Neuroprotection in metabolism-based therapy

Epilepsy Research

Volumn 100, Issue 3, 2012, Pages 286-294

  Hartman, Adam L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Calorie restriction; Epilepsy; Ketogenic diet; Neuroprotection; Parkinson disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 HYDROXYBUTYRIC ACID; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; CARBIDOPA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; KETONE BODY; LEVODOPA; MAMMALIAN TARGET OF RAPAMYCIN; MEDIUM CHAIN TRIACYLGLYCEROL; SIRTUIN 1;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTICONVULSANT THERAPY; APOPTOSIS; ARTICLE; AUTOPHAGY; BRAIN ISCHEMIA; CALORIC RESTRICTION; CELL FUNCTION; CELL VIABILITY; CLINICAL EFFECTIVENESS; COGNITION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG ABSORPTION; DRUG DOSE REDUCTION; EPILEPSY; EPILEPTIC STATE; EXCITOTOXICITY; GENOTYPE; HEART MUSCLE ISCHEMIA; HUMAN; KETOGENIC DIET; METABOLISM; METABOLISM BASED THERAPY; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; TRAUMATIC BRAIN INJURY; TREATMENT FAILURE; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE;

ALZHEIMER DISEASE; ANIMALS; CALORIC RESTRICTION; HUMANS; KETOGENIC DIET; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE;

EID: 84864080763     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.04.016     Document Type: Article

References (81)

1. Aguado C., Sarkar S., Korolchuk V.I., Criado O., Vernia S., Boya P., Sanz P., De Cordoba S.R., Knecht E., Rubinsztein D.C. Laforin, the most common protein mutated in Lafora disease, regulates autophagy. Hum. Mol. Genet. 2010, 19:2867-2876.
2. Ahola-Erkkila S., Carroll C.J., Peltola-Mjosund K., Tulkki V., Mattila I., Seppanen-Laakso T., Oresic M., Tyynismaa H., Suomalainen A. Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum. Mol. Genet. 2010, 19:1974-1984.
3. Al-Zaid N.S., Dashti H.M., Mathew T.C., Juggi J.S. Low carbohydrate ketogenic diet enhances cardiac tolerance to global ischaemia. Acta Cardiol. 2007, 62:381-389.
4. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995, 15:961-973.
5. Bailey E.E., Pfeifer H.H., Thiele E.A. The use of diet in the treatment of epilepsy. Epilepsy Behav. 2005, 6:4-8.
6. Balietti M., Giorgetti B., Fattoretti P., Grossi Y., Di Stefano G., Casoli T., Platano D., Solazzi M., Orlando F., Aicardi G., Bertoni-Freddari C. Ketogenic diets cause opposing changes in synaptic morphology in CA1 hippocampus and dentate gyrus of late-adult rats. Rejuvenation Res. 2008, 11:631-640.
7. Balietti M., Giorgetti B., Di Stefano G., Casoli T., Platano D., Solazzi M., Bertoni-Freddari C., Aicardi G., Lattanzio F., Fattoretti P. A ketogenic diet increases succinic dehydrogenase (SDH) activity and recovers age-related decrease in numeric density of SDH-positive mitochondria in cerebellar Purkinje cells of late-adult rats. Micron 2010, 41:143-148.
8. Baum L., Hansen L., Masliah E., Saitoh T. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation. Mol. Chem. Neuropathol. 1996, 29:253-261.
9. Bough K.J., Rho J.M. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007, 48:43-58.
10. Bough K.J., Wetherington J., Hassel B., Pare J.F., Gawryluk J.W., Greene J.G., Shaw R., Smith Y., Geiger J.D., Dingledine R.J. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 2006, 60:223-235.
11. Bruce-Keller A.J., Umberger G., Mcfall R., Mattson M.P. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 1999, 45:8-15.
12. Cardinali S., Canafoglia L., Bertoli S., Franceschetti S., Lanzi G., Tagliabue A., Veggiotti P. A pilot study of a ketogenic diet in patients with Lafora body disease. Epilepsy Res. 2006, 69:129-134.
13. Carloni S., Girelli S., Scopa C., Buonocore G., Longini M., Balduini W. Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia. Autophagy 2010, 6:366-377.
14. Cheng W.C., Berman S.B., Ivanovska I., Jonas E.A., Lee S.J., Chen Y., Kaczmarek L.K., Pineda F., Hardwick J.M. Mitochondrial factors with dual roles in death and survival. Oncogene 2006, 25:4697-4705.
15. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., Allison D.B., Cruzen C., Simmons H.A., Kemnitz J.W., Weindruch R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
16. Danial N.N., Gramm C.F., Scorrano L., Zhang C.Y., Krauss S., Ranger A.M., Datta S.R., Greenberg M.E., Licklider L.J., Lowell B.B., Gygi S.P., Korsmeyer S.J. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 2003, 424:952-956.
17. Duan W., Guo Z., Mattson M.P. Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice. J. Neurochem. 2001, 76:619-626.
18. Gorman A.M. Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J. Cell. Mol. Med. 2008, 12:2263-2280.
19. Greene A.E., Todorova M.T., Mcgowan R., Seyfried T.N. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 2001, 42:1371-1378.
20. Halagappa V.K., Guo Z., Pearson M., Matsuoka Y., Cutler R.G., Laferla F.M., Mattson M.P. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2007, 26:212-220.
21. Hansen S.L., Nielsen A.H., Knudsen K.E., Artmann A., Petersen G., Kristiansen U., Hansen S.H., Hansen H.S. Ketogenic diet is antiepileptogenic in pentylenetetrazole kindled mice and decrease levels of N-acylethanolamines in hippocampus. Neurochem. Int. 2009, 54:199-204.
22. Hartman A.L., Vining E.P. Clinical aspects of the ketogenic diet. Epilepsia 2007, 48:31-42.
23. Hartman A.L., Zheng X., Bergbower E., Kennedy M., Hardwick J.M. Seizure tests distinguish intermittent fasting from the ketogenic diet. Epilepsia 2010, 51:1395-1402.
24. Hemingway C., Freeman J.M., Pillas D.J., Pyzik P.L. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics 2001, 108:898-905.
25. Henderson S.T., Vogel J.L., Barr L.J., Garvin F., Jones J.J., Costantini L.C. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr. Metab. (Lond.) 2009, 6:31.
26. Hori A., Tandon P., Holmes G.L., Stafstrom C.E. Ketogenic diet: effects on expression of kindled seizures and behavior in adult rats. Epilepsia 1997, 38:750-758.
27. Jabre M.G., Bejjani B.P. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology 2006, 66:617. (author reply 617).
28. Jaeger P.A., Wyss-Coray T. Beclin 1 complex in autophagy and Alzheimer disease. Arch. Neurol. 2010, 67:1181-1184.
29. Juge N., Gray J.A., Omote H., Miyaji T., Inoue T., Hara C., Uneyama H., Edwards R.H., Nicoll R.A., Moriyama Y. Metabolic control of vesicular glutamate transport and release. Neuron 2010, 68:99-112.
30. Kang H.C., Lee Y.M., Kim H.D., Lee J.S., Slama A. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 2007, 48:82-88.
31. Kashiwaya Y., Takeshima T., Mori N., Nakashima K., Clarke K., Veech R.L. d-Beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5440-5444.
32. Knecht E., Aguado C., Sarkar S., Korolchuk V.I., Criado-Garcia O., Vernia S., Boya P., Sanz P., Rodriguez De Cordoba S., Rubinsztein D.C. Impaired autophagy in Lafora disease. Autophagy 2010, 6:991-993.
33. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880-884.
34. Kossoff E.H., Krauss G.L., Mcgrogan J.R., Freeman J.M. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology 2003, 61:1789-1791.
35. Krueger D.A., Care M.M., Holland K., Agricola K., Tudor C., Mangeshkar P., Wilson K.A., Byars A., Sahmoud T., Franz D.N. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N. Engl. J. Med. 2010, 363:1801-1811.
36. Laplante M., Sabatini D.M. mTOR signaling at a glance. J. Cell. Sci. 2009, 122:3589-3594.
37. Lau A., Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010, 460:525-542.
38. Lee J., Bruce-Keller A.J., Kruman Y., Chan S.L., Mattson M.P. 2-Deoxy-d-glucose protects hippocampal neurons against excitotoxic and oxidative injury: evidence for the involvement of stress proteins. J. Neurosci. Res. 1999, 57:48-61.
39. Li H., Chen Y., Jones A.F., Sanger R.H., Collis L.P., Flannery R., Mcnay E.C., Yu T., Schwarzenbacher R., Bossy B., Bossy-Wetzel E., Bennett M.V., Pypaert M., Hickman J.A., Smith P.J., Hardwick J.M., Jonas E.A. Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2169-2174.
40. Lian X.Y., Khan F.A., Stringer J.L. Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats. J. Neurosci. 2007, 27:12007-12011.
41. Maalouf M., Sullivan P.G., Davis L., Kim D.Y., Rho J.M. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 2007, 145:256-264.
42. Maalouf M., Rho J.M., Mattson M.P. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res. Rev. 2009, 59:293-315.
43. Marie C., Bralet A.M., Gueldry S., Bralet J. Fasting prior to transient cerebral ischemia reduces delayed neuronal necrosis. Metab. Brain Dis. 1990, 5:65-75.
44. Masino S.A., Kawamura M., Wasser C.A., Pomeroy L.T., Ruskin D.N. Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity. Curr. Neuropharmacol. 2009, 7:257-268.
45. Massieu L., Del Rio P., Montiel T. Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates. Neuroscience 2001, 106:669-677.
46. Maswood N., Young J., Tilmont E., Zhang Z., Gash D.M., Gerhardt G.A., Grondin R., Roth G.S., Mattison J., Lane M.A., Carson R.E., Cohen R.M., Mouton P.R., Quigley C., Mattson M.P., Ingram D.K. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:18171-18176.
47. Muller-Schwarze A.B., Tandon P., Liu Z., Yang Y., Holmes G.L., Stafstrom C.E. Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model. Neuroreport 1999, 10:1517-1522.
48. Nabbout R., Mazzuca M., Hubert P., Peudennier S., Allaire C., Flurin V., Aberastury M., Silva W., Dulac O. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010, 51:2033-2037.
49. Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G., Whitney A., Cross J.H. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008, 7:500-506.
50. Nikanorova M., Miranda M.J., Atkins M., Sahlholdt L. Ketogenic diet in the treatment of refractory continuous spikes and waves during slow sleep. Epilepsia 2009, 50:1127-1131.
51. Niquet J., Wasterlain C.G. Bim, Bad, and Bax: a deadly combination in epileptic seizures. J. Clin. Invest. 2004, 113:960-962.
52. Noh H.S., Kim Y.S., Lee H.P., Chung K.M., Kim D.W., Kang S.S., Cho G.J., Choi W.S. The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res. 2003, 53:119-128.
53. Noh H.S., Kim Y.S., Kim Y.H., Han J.Y., Park C.H., Kang A.K., Shin H.S., Kang S.S., Cho G.J., Choi W.S. Ketogenic diet protects the hippocampus from kainic acid toxicity by inhibiting the dissociation of bad from 14-3-3. J. Neurosci. Res. 2006, 84:1829-1836.
54. Nylen K., Velazquez J.L., Sayed V., Gibson K.M., Burnham W.M., Snead O.C. The effects of a ketogenic diet on ATP concentrations and the number of hippocampal mitochondria in Aldh5a1(-/-) mice. Biochim. Biophys. Acta 2009, 1790(20):8-12.
55. Orlova K.A., Crino P.B. The tuberous sclerosis complex. Ann. N. Y. Acad. Sci. 2010, 1184:87-105.
56. Pfeifer H.H., Thiele E.A. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005, 65:1810-1812.
57. Porta N., Vallee L., Lecointe C., Bouchaert E., Staels B., Bordet R., Auvin S. Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, exerts anticonvulsive properties. Epilepsia 2009, 50:943-948.
58. Puchowicz M.A., Zechel J.L., Valerio J., Emancipator D.S., Xu K., Pundik S., Lamanna J.C., Lust W.D. Neuroprotection in diet-induced ketotic rat brain after focal ischemia. J. Cereb. Blood Flow Metab. 2008, 28:1907-1916.
59. Qin W., Yang T., Ho L., Zhao Z., Wang J., Chen L., Zhao W., Thiyagarajan M., Macgrogan D., Rodgers J.T., Puigserver P., Sadoshima J., Deng H., Pedrini S., Gandy S., Sauve A.A., Pasinetti G.M. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 2006, 281:21745-21754.
60. Reyes N.A., Fisher J.K., Austgen K., Vandenberg S., Huang E.J., Oakes S.A. Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis. J. Clin. Invest. 2010, 120:3673-3679.
61. Rho J.M., Anderson G.D., Donevan S.D., White H.S. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 2002, 43:358-361.
62. Samala R., Willis S., Borges K. Anticonvulsant profile of a balanced ketogenic diet in acute mouse seizure models. Epilepsy Res. 2008, 81:119-127.
63. Samoilova M., Weisspapir M., Abdelmalik P., Velumian A.A., Carlen P.L. Chronic in vitro ketosis is neuroprotective but not anti-convulsant. J. Neurochem. 2010, 113:826-835.
64. Santra S., Gilkerson R.W., Davidson M., Schon E.A. Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells. Ann. Neurol. 2004, 56:662-669.
65. Semenza G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007 2007, cm8.
66. Sims-Robinson C., Kim B., Rosko A., Feldman E.L. How does diabetes accelerate Alzheimer disease pathology?. Nat. Rev. Neurol. 2010, 6:551-559.
67. Spilman P., Podlutskaya N., Hart M.J., Debnath J., Gorostiza O., Bredesen D., Richardson A., Strong R., Galvan V. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 2010, 5:e9979.
68. Stafstrom C.E., Ockuly J.C., Murphree L., Valley M.T., Roopra A., Sutula T.P. Anticonvulsant and antiepileptic actions of 2-deoxy-d-glucose in epilepsy models. Ann. Neurol. 2009, 65:435-447.
69. Studzinski C.M., Mackay W.A., Beckett T.L., Henderson S.T., Murphy M.P., Sullivan P.G., Burnham W.M. Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-beta precursor protein (APP) levels in the aged dog. Brain Res. 2008, 1226:209-217.
70. Suzuki M., Kitamura Y., Mori S., Sato K., Dohi S., Sato T., Matsuura A., Hiraide A. Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia. Jpn. J. Pharmacol. 2002, 89:36-43.
71. Tai K.K., Nguyen N., Pham L., Truong D.D. Ketogenic diet prevents cardiac arrest-induced cerebral ischemic neurodegeneration. J. Neural. Transm. 2008, 115:1011-1017.
72. Tieu K., Perier C., Caspersen C., Teismann P., Wu D.C., Yan S.D., Naini A., Vila M., Jackson-Lewis V., Ramasamy R., Przedborski S. d-Beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J. Clin. Invest. 2003, 112:892-901.
73. Todorova M.T., Tandon P., Madore R.A., Stafstrom C.E., Seyfried T.N. The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia 2000, 41:933-940.
74. Van Der Auwera I., Wera S., Van Leuven F., Henderson S.T. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr. Metab. (Lond.) 2005, 2:28.
75. Vanitallie T.B., Nonas C., Di Rocco A., Boyar K., Hyams K., Heymsfield S.B. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology 2005, 64:728-730.
76. Willis S., Stoll J., Sweetman L., Borges K. Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models. Neurobiol. Dis. 2010, 40:565-572.
77. Wusthoff C.J., Kranick S.M., Morley J.F., Christina Bergqvist A.G. The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus. Epilepsia 2010, 51:1083-1085.
78. Xu K., Sun X., Eroku B.O., Tsipis C.P., Puchowicz M.A., Lamanna J.C. Diet-induced ketosis improves cognitive performance in aged rats. Adv. Exp. Med. Biol. 2010, 662:71-75.
79. Yang Z., Klionsky D.J. Eaten alive: a history of macroautophagy. Nat. Cell. Biol. 2010, 12:814-822.
80. Zeng L.H., Rensing N.R., Wong M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J. Neurosci. 2009, 29:6964-6972.
81. Zhao Z., Lange D.J., Voustianiouk A., Macgrogan D., Ho L., Suh J., Humala N., Thiyagarajan M., Wang J., Pasinetti G.M. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006, 7:29.